Catheter Precision Inc.

Flyte, the Regional Air Mobility subsidiary of Catheter Precision, has entered a strategic partnership with Blade Urban Air Mobility to feature its Cirrus Vision Jet fleet on Blade's platform. The agreement is expected to increase aircraft utilization, customer acquisition, brand awareness, and platform-driven revenue opportunities for Flyte by providing Blade passengers access to a modern, efficient, and cost-effective private aviation solution for regional travel. Flyte believes its Vision Jet fleet is uniquely positioned to complement Blade's customer base, which has historically focused on premium, time-sensitive regional travel solutions. The partnership is non-exclusive and subject to the terms and conditions of the parties' agreement.

Flyte, the regional air mobility subsidiary of Catheter Precision, announced a strategic partnership with LifeVac to equip its fleet of Cirrus Vision Jets with LifeVac's airway clearance device for choking emergencies. The partnership extends Flyte's safety program from the flight deck into the cabin, ensuring each aircraft is prepared for medical emergencies. LifeVac is the first and only suction anti-choking device to receive FDA De Novo authorization, cleared as a second-line treatment after standard choking-rescue protocols, and has been credited in more than 6,200 reported choking rescues worldwide. Placing LifeVac devices on every aircraft provides crews with an additional tool to respond to in-flight choking incidents where outside help is not available. Flyte's broader safety ecosystem integrates multiple layers of protection, including the Cirrus Airframe Parachute System, Safe Return Emergency Autoland technology, advanced Garmin flight deck systems, and a standardized fleet built entirely around the Vision Jet to reduce operational variables.

Flyte, a subsidiary of Catheter Precision, announced continued operational growth following the launch of its enhanced digital booking platform, www.flyflyte.com. During the first six months of 2026, Flyte acquired more than 1,000 new platform users, facilitated 118 flights across its growing network, and generated more than $1.0 million in revenue. The platform allows customers to instantly price and book a Flyte Jet through a seamless digital experience, and is also designed to support aviation brokers, travel advisors, and strategic partners. Flyte exclusively operates a fleet of Cirrus Vision Jets, purpose-built for short-haul travel, offering access to thousands of private airports with jet-speed performance and industry-leading safety features. Founder and CEO Marc Sellouk stated that early results have been extremely encouraging, with strong growth from both direct bookings and an expanding network of broker and strategic partners.

Flyte, the regional air mobility subsidiary of Catheter Precision, announced a partnership with sports agency GSE Worldwide and PGA TOUR professional Emiliano Grillo that debuted at the 2026 U.S. Open. Grillo climbed as high as third place during the championship and finished tied for 23rd after a strong Saturday round of 3-under-par 67. The collaboration aims to showcase Flyte's fleet of Cirrus Vision Jets as a faster, more flexible travel option for elite athletes managing demanding regional schedules. CEO Marc Sellouk called the partnership a natural fit and the start of an expected long-term relationship with both GSE and Grillo. The deal positions Flyte within the professional sports ecosystem through one of the industry's premier talent agencies.